ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
다우존스 지수
42,840.26
1.18%
Bitcoin
97,226.90
0.02%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Werewolf Therapeutics Inc (HOWL)

  7. Werewolf Therapeutics Inc (HOWL) 뉴스

Werewolf Therapeutics Inc

Werewolf Therapeutics Inc (HOWL)

NASDAQ
1.59
0.02
(1.27%)
마감 22 12월 6:00AM
15분 지연
1.59
0.015
(0.95%)
시간외 거래: 9:59AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

HOWL 뉴스

공식 뉴스 전용

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
07 11월 2024
HOWL (1.27%)

Form 8-K - Current report
Edgar (US Regulatory)
07 11월 2024
HOWL (1.27%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
08 8월 2024
HOWL (1.27%)

Form 8-K - Current report
Edgar (US Regulatory)
08 8월 2024
HOWL (1.27%)

Form 8-K - Current report
Edgar (US Regulatory)
03 6월 2024
HOWL (1.27%)

HOWL Discussion

게시물 보기
tw0122 tw0122 2 월 전
Halloween is here again give it another howl. Flip time coming $4.45
👍️0
tw0122 tw0122 2 월 전
$3.65 + 30% HOWLing a little some.. Title: INDUKINE™ Molecules Delivering Various Cytokines Utilize Unique Mechanisms of Action to Drive Anti-Tumor Efficacy in Murine Syngeneic Tumor Models
Abstract Number: 955
Session Date and Time: Friday, Nov. 8, 2024; 9 a.m.–8:30 p.m.
Location: George R. Brown Convention Center - Exhibit Halls A B

Title: The tumor-activated IL-12 prodrug WTX-330 expanded/activated tumor infiltrating lymphocytes and caused tumor regression in patients with refractory solid tumors: Interim data from an ongoing Ph1 study
Abstract Number: 672
Session Date and Time: Saturday, Nov. 9, 2024; 9 a.m.–8:30 p.m.
Location: George R. Brown Convention Center - Exhibit Halls A B

About Werewolf Therapeutics
Werewolf Therapeutics, Inc., is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. Werewolf leverages its proprietary PREDATOR® platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. The Company’s INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Werewolf’s most advanced clinical stage product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules, respectively, for the treatment of solid tumors. Werewolf is advancing WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor and WTX-330 as a single agent in multiple tumor types and Non-Hodgkin Lymphoma. To learn more visit www.werewolftx.com.

WEREWOLF®, the WEREWOLF logo, PREDATOR®, INDUKINE™ and other Werewolf trademarks, service marks, graphics and logos are trade names, trademarks or registered trademarks of Werewolf Therapeutics, Inc., in the United States or other countries. All rights reserved.

👍️0
Monksdream Monksdream 4 월 전
HOWL under $3
👍️0
Monksdream Monksdream 5 월 전
HOWL under $3
👍️0
Monksdream Monksdream 8 월 전
HOWL under $10
👍️0
Monksdream Monksdream 12 월 전
HOWL new 52 week high
👍️0
Pt3 Pt3 1 년 전
Yea your gap and trapped make me buy caud instead of this
👍️0
TheFinalCD TheFinalCD 1 년 전
HOWL todays algo patented Gap & Trap on Phase #1 news
👍️0
TheFinalCD TheFinalCD 1 년 전
https://twitter.com/Ainvest_Wire/status/1720407693737840751
👍️0
TheFinalCD TheFinalCD 1 년 전
$howl flying https://finviz.com/quote.ashx?t=HOWL&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/HOWL
👍️0
tw0122 tw0122 1 년 전
$3 + otw Halloween is here give it a HOWL
👍️0
The Night Stalker The Night Stalker 1 년 전
https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
👍️0
The Night Stalker The Night Stalker 1 년 전
https://stockcharts.com/h-sc/ui?s=howl&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
👍️0
The Night Stalker The Night Stalker 2 년 전
dip
👍️0
The Night Stalker The Night Stalker 2 년 전
dip
👍️0
The Night Stalker The Night Stalker 2 년 전
watching
👍️0
The Night Stalker The Night Stalker 2 년 전
soon
👍️0
The Night Stalker The Night Stalker 2 년 전
insert dd
👍️0
The Night Stalker The Night Stalker 2 년 전
can be big
👍️0
The Night Stalker The Night Stalker 2 년 전
wow
👍️0
The Night Stalker The Night Stalker 2 년 전
wow
👍️0
The Night Stalker The Night Stalker 2 년 전
hold
👍️0
The Night Stalker The Night Stalker 2 년 전
slow
👍️0
The Night Stalker The Night Stalker 2 년 전
slow
👍️0
The Night Stalker The Night Stalker 2 년 전
agreed
👍️0
The Night Stalker The Night Stalker 2 년 전
like thiks
👍️0
The Night Stalker The Night Stalker 2 년 전
off radar
👍️0
The Night Stalker The Night Stalker 2 년 전
catchy name
👍️0
The Night Stalker The Night Stalker 2 년 전
catchy name
👍️0
surf1944 surf1944 2 년 전
https://stockcharts.com/h-sc/ui?s=howl&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/howl/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/howl/opinion
👍️0
Mr. Zen Mr. Zen 2 년 전
Watch list addition, this has the potential to run, just waiting for all the pieces of the puzzle to come together.

“These promising preclinical data add to a growing body of evidence demonstrating the potential of WTX-330 to drive targeted anti-tumor immune responses selectively in the tumor microenvironment (TME),” said Cynthia Seidel-Dugan, Ph.D., Chief Scientific Officer of Werewolf Therapeutics. “This morning, in our Third Quarter 2022 release, we announced that the FDA has granted clearance of the investigational new drug (IND) application for WTX-330. We are excited to advance WTX-330 into the clinic and to continue developing a pipeline of novel proinflammatory cytokine therapies that have the potential to change the lives of cancer patients.”
👍️0
makinezmoney makinezmoney 2 년 전
$HOWL: Hey thanks....... now 3.20.

Only getting better right ??


Enjoy those profits.





GO $HOWL
👍️0
Makk1 Makk1 2 년 전
Good call here, looking very good
👍️0
makinezmoney makinezmoney 2 년 전
$HOWL: Looks like its turning...... now 2.25

Let see if volume pushes it up.


The setup is nice


GO $HOWL
👍️0
bobbo5 bobbo5 2 년 전
I agree and it looks like share price has been moving up this past week
👍️0
dia76ca dia76ca 2 년 전
Very interesting company. I like it's chances.
👍️0

최근 히스토리

NASDAQ
HOWL
Werewolf Therapeutics
LSE
RUR
Rurelec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유